IMVT compared with ROIV: revenue, margins and what each company keeps, and the suppliers and customers both name

IMVTImmunovant, Inc.

Mkt capRevenueRevenue

ROIVRoivant Sciences Ltd.

Mkt capRevenueRevenue

Compare

IMVTImmunovant, Inc.

ROIVRoivant Sciences Ltd.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Co-movers

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Co-movers

daily closes · 500dMethod ›

Moved together

IMVTwithROIV

×0.43co-movement · ROIV on IMVT · 500d

r 0.61scale to r 0.75

Shared co-movers5with IMVTwith ROIV

XNCRXencor Incr 0.41r 0.41

CLDXCelldex Therapeutics, Inc.r 0.44r 0.39

IDYAIDEAYA Biosciences, Inc.r 0.49r 0.38

DNLIDenali Therapeutics Inc.r 0.45r 0.38

KURAKura Oncology, Inc.r 0.46r 0.38

IMVT, solidROIV, hatched× = co-movement · βr = correlationBar = r to r 0.75Order: weaker of A and BSource: daily closes

IMVTImmunovant, Inc.

28.410.00%· post 29.00· delayed

Mkt cap$5.9BRevenue—Revenue—

ROIVRoivant Sciences Ltd.

35.89▲+0.01%· post 36.07· delayed

After hoursNov 3 '26delayed

Mkt cap$26.0BRevenue$1MQ1 FY26Revenue$8MFY25

Compare

After hoursNov 3 '26delayed

IMVTImmunovant, Inc.

ROIVRoivant Sciences Ltd.

28.410.00%post 29.00delayed

Price

35.89▲+0.01%post 36.07delayed

$5.9B

Mkt cap

$26.0B

—

Revenue

$1MQ1 FY26

—

Revenue

$8MFY25

IMVT28.410.00%vsROIV35.89▲+0.01%After hoursNov 3 '26delayed